Atlas Trials

Pharmacokinetics of Apixaban in Nephrotic Syndrome

Clinical trial NCT02599532 · COMPLETED

Trial details

NCT number
NCT02599532
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Nephrotic SyndromeProteinuria
Start date
2017-04-30
Primary completion
2019-06-28
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.